Your browser doesn't support javascript.
loading
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Marcq, Gautier; Foerster, Beat; Abufaraj, Mohammad; Matin, Surena F; Azizi, Mounsif; Gupta, Mohit; Li, Wei-Ming; Seisen, Thomas; Clinton, Timothy; Xylinas, Evanguelos; Mir, M Carmen; Schweitzer, Donald; Mari, Andrea; Kimura, Shoji; Bandini, Marco; Mathieu, Romain; Ku, Ja H; Guruli, Georgi; Grabbert, Markus; Czech, Anna K; Muilwijk, Tim; Pycha, Armin; D'Andrea, David; Petros, Firas G; Spiess, Philippe E; Bivalacqua, Trinity; Wu, Wen-Jeng; Rouprêt, Morgan; Krabbe, Laura-Maria; Hendricksen, Kees; Egawa, Shin; Briganti, Alberto; Moschini, Marco; Graffeille, Vivien; Autorino, Riccardo; John, Patricia; Heidenreich, Axel; Chlosta, Piotr; Joniau, Steven; Soria, Francesco; Pierorazio, Phillip M; Shariat, Shahrokh F; Kassouf, Wassim.
Afiliação
  • Marcq G; Department of Surgery, Division of Urology, McGill University Health Center, Montreal, Canada; Urology Department, Claude Huriez Hospital, CHU Lille, Lille, France.
  • Foerster B; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland.
  • Abufaraj M; Department of Urology, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.
  • Matin SF; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
  • Azizi M; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Surgery, Division of Urology, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Canada.
  • Gupta M; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Li WM; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Urology, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Seisen T; Urology, GRC 5, Predictive ONCO-URO, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.
  • Clinton T; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Paris Descartes University, Paris, France.
  • Mir MC; Instituto Valenciano de Oncologia Foundation, Valencia, Spain.
  • Schweitzer D; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Mari A; Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Kimura S; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Bandini M; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • Mathieu R; Department of Urology, University of Rennes, Rennes, France.
  • Ku JH; Department of Urology, Seoul National University Hospital, Seoul, Korea.
  • Guruli G; Division of Urology, Virginia Commonwealth University, Richmond, VA, USA.
  • Grabbert M; Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany.
  • Czech AK; Department of Urology, Jagiellonian University Medical College, Krakow, Poland.
  • Muilwijk T; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Pycha A; Department of Urology, Provincial Hospital of Bozen, Bozen, Italy; Medical School, Sigmund Freud University, Vienna, Austria.
  • D'Andrea D; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Petros FG; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA; Department of Urology and Kidney Transplant, The University of Toledo Medical Center and Eleanor N. Dana Cancer Center, Toledo, OH, USA.
  • Spiess PE; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Bivalacqua T; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wu WJ; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Urology, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Rouprêt M; Urology, GRC 5, Predictive ONCO-URO, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.
  • Krabbe LM; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University Hospital Muenster, Muenster, Germany.
  • Hendricksen K; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Egawa S; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Briganti A; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • Moschini M; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Graffeille V; Department of Urology, University of Rennes, Rennes, France.
  • Autorino R; Division of Urology, Virginia Commonwealth University, Richmond, VA, USA.
  • John P; Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany.
  • Heidenreich A; Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany.
  • Chlosta P; Department of Urology, Jagiellonian University Medical College, Krakow, Poland.
  • Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Soria F; Department of Urology, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Surgical Sciences, University of Torino School of Medicine, Turin, Italy.
  • Pierorazio PM; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urolog
  • Kassouf W; Department of Surgery, Division of Urology, McGill University Health Center, Montreal, Canada. Electronic address: wassim.kassouf@muhc.mcgill.ca.
Eur Urol Focus ; 8(2): 491-497, 2022 03.
Article em En | MEDLINE | ID: mdl-33773965
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article